SEC Form 4 · accession 0001209191-19-000963
SOPHIRIS BIO INC. · SPHS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allison Hulme
Officer — Chief Operating Officer · Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563855
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (Right to Buy)F1 | $0.83 | Dec 31, 2018 | A | 245,000 | A | Dec 21, 2019 | Dec 30, 2028 | Common Stock | 245,000 | 245,000 | D |
Explanation of responses
- F133% of the shares subject to the option shall vest on December 21, 2019. The remainder shall vest monthly thereafter over the next two years until fully vested on December 21, 2021.